Helmerich & Payne, Inc.·4

Mar 6, 4:06 PM ET

Chariag Belgacem 4

4 · Helmerich & Payne, Inc. · Filed Mar 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Helmerich & Payne (HP) Director Chariag Belgacem Receives Award of 5,273 Shares

What Happened Chariag Belgacem, a director of Helmerich & Payne, was granted 5,273 shares on 2026-03-05 as an award (transaction code A). The reported acquisition price is $0.00, so the grant did not involve a cash purchase; the reported dollar value of the acquisition is $0 on the Form 4 excerpt provided. This is an equity award (compensation/benefit) rather than an open-market buy or sale.

Key Details

  • Transaction date: 2026-03-05; Form 4 filed: 2026-03-06 (timely filing).
  • Transaction type/code: A = Award/Grant (acquisition).
  • Shares acquired: 5,273; acquisition price reported: $0.00; reported value: $0 on the filing excerpt.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • No footnotes (e.g., 10b5-1 plan or tax-withholding details) were provided in the excerpt; none indicated.
  • This is an award (non‑sale); not a cash purchase or sale that directly signals market trading intent.

Context Director equity awards are commonly used for compensation and are often subject to vesting or holding restrictions; a $0 reported price typically reflects a grant rather than a market purchase. Such awards are routine and do not by themselves indicate the director’s short‑term market sentiment.

Insider Transaction Report

Form 4
Period: 2026-03-05
Transactions
  • Award

    Common Stock

    2026-03-05+5,27367,056 total
Signature
/s/ William H. Gault by Power of Attorney for Belgacem Chariag|2026-03-06

Documents

1 file
  • 4
    form4-03062026_090317.xmlPrimary